Business
Bioceltix Signs Advisory Agreement For FDA Regulatory Support
Bioceltix Signs Advisory Agreement For FDA Regulatory Support
About this update from Bioceltix Sa
Bioceltix S.A. GPW:BCX:SAID ON MONDAY THAT IT HAD SIGNED AN ADVISORY AGREEMENT FOR REGULATORY SUPPORT OF VETERINARY STEM CELL PRODUCTS IN US MARKETPARTNER TO ASSIST IN DIALOGUE WITH U.S. FOOD AND DRUG ADMINISTRATION (FDA) AND CENTER FOR VETERINARY MEDICINE (CVM)AGREEMENT SIGNED FOR PERIOD OF UP TO 3 YEARSESTIMATES ABOUT 6 TO 9 MONTHS TO REACH FIRST MEETING WITH FDA/CVMPOTENTIAL ADMINISTRATIVE FEE TOTALS $165,441 IF FEE WAIVER IS NOT GRANTEDSource text:Further company coverage: